GRANULESNSEGranules India Limited· PharmaceuticalsLowNeutral
Announced Wed, 7 May · 17:01 IST

Granules India Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

GRANULES · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Granules India Limited has scheduled an analyst and investor earnings conference call to discuss its financial performance and business updates for Q4 and the financial year ended March 31, 2025. The call is set for Wednesday, May 28, 2025, at 5:00 PM IST. Key participants include Dr. Krishna Prasad Chigurupati (Chairman & MD), Dr. KVS Ram Rao (Joint MD & CEO), Ms. Priyanka Chigurupati (Executive Director), and Mr. Mukesh Surana (CFO). The filing includes dial-in numbers for domestic and international participants, along with a pre-registration link. This is a routine disclosure made under SEBI Listing Regulations.

Likely market impact

This is a procedural announcement and is unlikely to move the stock on its own. However, it signals that the company's Q4 FY25 results are imminent, which could drive investor attention and potential volatility around the results date.